Alzinova AB’s Post

Engaging discussions on day 1 at the Reuters event Pharma 2024 in Barcelona today. Key themes revolved around equity in healthcare access and sustainability. Stefan Oelrich kickstarted the day questioning the feasibility of funding innovative treatments for diseases like Alzheimer’s or Parkinson’s. Later, Monica Shaw highlighted the stable healthcare budget allocation at 15%, despite significant innovation waves. This challenges the misconception that drug costs solely drive healthcare access and equity issues. As we navigate these complexities, how do we strike a balance for equitable healthcare access, acknowledging the industry's contributions to society and healthcare beyond just drug costs? #REPharma2024 #HealthcareEquity #Sustainability

Last week I participated in a panel "IVDs - how will the future of diagnostics ecosystems change?" at the #MedTechForum in Vienna. Together with other panellists Daniela Delledonne, Prateek Natani and Oliver Bisazza, we discussed the current state of the diagnostic market, considered its strongest trends, and looked at the areas for key technologies and sector evolution. My takeaways from the panel are below:         🔵 The health systems must focus on building resilience, investing in prevention & healthcare workforce retention, and ensuring timely access to care post-Covid-19         🔵 We see a growing demand for developing new diagnostic tests from both customers and patients, particularly to fight antimicrobial resistance (AMR)         🔵 Point-of-care testing (POCT) testing requires investment, but it saves costs in the long run by reducing hospital stays and ensuring appropriate antibiotic use         🔵 The sustainability laws require manufacturers to do better and deliver solutions by lowering carbon footprint for healthcare providers Exciting times ahead of us and so pleased to be part of the journey. Thank you MedTech Europe for the invite! #MedTechForum #HealthcareInnovation #HealthcareTrends  

Hi LinkedIn, I’d like to introduce you to Medesol Health, Inc., where we’re pioneering affordable and scalable therapeutic and decontamination solutions to address global healthcare challenges. While healthcare innovation is advancing at an incredible pace, many solutions are out of reach for billions in low- and middle-income countries who face common, yet devastating, health issues like untreated burns, infections, and parasitic diseases. The real need? Accessible, reliable care—not $300,000 treatments, but affordable technologies that can make a meaningful impact. At Medesol Health, we’re committed to delivering low-cost, scalable innovations that tackle both current and emerging healthcare challenges head-on. As we look to scale, we’re seeking investment partners who share our vision of making transformative healthcare technology accessible to all. If you’re passionate about impactful investments in healthcare, I’d love to connect and discuss how we can collaborate to drive meaningful change. Let’s chat! #healthcareinnovation #impactinvesting #biotechnology #affordablecare #globalhealth

📣 The 2030 Vision: The Economic Potential and Future of Nordic Healthcare Join our panel of Life Science Leaders as they discuss: · How exactly can health data be leveraged to make the Nordic vision a reality? · Key challenges and opportunities of making real a new integrated and sustainable healthcare system · Potential economic effects on the Nordic region 🎙 Hear from: · Troels Bierman Mortensen, CEO, DataFair. · Frederik Knud Nielsen, Healthcare Partnerships Director, Novartis Denmark · Kenneth Forsstrøm Jensen, Health Data Lead, Roche Find out more: https://lnkd.in/e73A7vdR #LSXNordic #Biotech #Medtech #Healthtech

Our CEO, Bill Brown, just took center stage on the latest episode of The 10 Minute HealthBizCast with Bobby Guy! 🎙️ He dives into Genomind’s mission and groundbreaking pharmacogenetics testing, highlighting how we’re transforming healthcare through rapid, incremental change. 🌍 Don’t miss out on this powerful episode with insights into the biotech revolution. Catch the episode now and learn how Genomind is shaping the future of personalized medicine! 🔗 Listen now: https://lnkd.in/eaUQGzKP #HealthcareInnovation #Pharmacogenetics #BiotechRevolution #Genomind #HealthBizCast #PersonalizedMedicine

Keynote at Swiss Nordic Bio: Exploring the Future of Healthcare - can we square a circle?   Last Thursday, I had the privilege to give a keynote speech at the Swiss Nordic Bio conference. Did you know that the Nordic countries and Switzerland rank among the world's happiest nations? The individual freedom we have and the ability to participate in the public debate and shape our societies are critical factors driving this happiness. As such the participants broadly agreed that we need to play an active role in ensuring innovation and high quality, accessible healthcare remains a top priority for our governments and societies, particularly in this pivotal year where EU Parliament but also many local governments are being elected.   We discussed what would be needed to "square the circle" in healthcare, i.e. solve the seemingly unsolvable problem of providing broader access and better quality care to a growing and aging population in light of scarce resources. We explore the role that data and technologies can play in supporting a seamless and highly effective care journey, from prevention, to diagnosis and treatment. And we acknowledged that, while required technologies are at our fingertips, the reality in clinical practice still looks very different.   To achieve the vision of data and technology enabled, more personalized care, we must cultivate the right people, forge meaningful partnerships, and enact progressive policies.  The journey ahead may seem daunting, but with determination and collaboration, we could square the circle in healthcare.   Thank you to the event main sponsors Nasdaq and Eversheds Sutherland and partners Innovation Norway, Vontobel, Embassy of Sweden, and Innosuisse Swiss Innovation Agency.   #PersonalizedHealthcare #swissnordicbio #investors #lifescience #innovation #biotech #medtech #Nordics #Switzerland #conference #healthcare

Last week, Kris Sterkens had the opportunity to speak at FT Live Global Pharma and Biotech Summit 2024, on the paradox of innovation and change in an evolving healthcare industry. Scientific breakthroughs have the potential to revolutionise the lives of those living with some of the most challenging health conditions. But outdated healthcare infrastructure and processes are preventing these new treatments from reaching the people who need them most. In a fireside chat, Kris discussed why these challenges exist in Europe and delved into the mismatch between groundbreaking medicine and barriers to treatment, highlighting how industry can help drive change. We must ensure that innovative treatments are accessible to all individuals who can benefit the most from them. Together, we can drive change. #FTPharma

🚀 New Episode Alert: 10 Minute Health BizCast 🚀 Tune in to Track 7 of the 10 Minute Health BizCast where we dive into the biotech revolution that's transforming healthcare. In this episode, we chat with Bill Brown, CEO of Genomind about their groundbreaking testing innovations that are making healthcare better and more personalized. Explore the opportunities in new diagnostics and the biotech advancements that are shaping the future of healthcare. Don’t miss out on this insightful conversation and the chance to learn from a leader at the forefront of the biotech revolution. Catch the latest episode now and join the conversation about how biotech is changing the game for healthcare. 🎧 https://lnkd.in/e77cCENJ #biotech #biotechrevolution #diagnosticsrevolution #healthcareleadership #healthbizcast #changinghealthcare

Read our feature article in Dagens Industri and discover where Nobel Biocare started - with Per-Ingvar Brånemark's groundbreaking discovery of osseointegration - to where we are now, with a unique digital ecosystem that creates a workflow that truly benefits users and patients: https://lnkd.in/exKUz-NQ